# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-037847
Filing Date
2023-11-08
Accepted
2023-11-08 16:12:06
Documents
76
Period of Report
2023-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | bcrx-20230930.htm iXBRL | 10-Q | 1446966
2 | EX-10.2 | exhibit102-inducementequit.htm | EX-10.2 | 87185
3 | EX-31.1 | bcrx-20230930xexx311.htm | EX-31.1 | 9587
4 | EX-31.2 | bcrx-20230930xexx312.htm | EX-31.2 | 9561
5 | EX-32.1 | bcrx-20230930xexx321.htm | EX-32.1 | 4633
6 | EX-32.2 | bcrx-20230930xexx322.htm | EX-32.2 | 4607
| Complete submission text file | 0001628280-23-037847.txt |  | 7850107

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | bcrx-20230930.xsd | EX-101.SCH | 63816
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | bcrx-20230930_cal.xml | EX-101.CAL | 53489
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | bcrx-20230930_def.xml | EX-101.DEF | 273200
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | bcrx-20230930_lab.xml | EX-101.LAB | 754445
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | bcrx-20230930_pre.xml | EX-101.PRE | 470154
70 | EXTRACTED XBRL INSTANCE DOCUMENT | bcrx-20230930_htm.xml | XML | 1072309

Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 231387970
SIC: 2836 Biological Products, (No Diagnostic Substances)